[1] |
Karbalaei M, Keikha M. Rescue effects of Lactobacillus-containing bismuth regimens after Helicobacter pylori treatment failure[J]. New Microbes New Infect, 2021, 42(8): 100904.
|
[2] |
Bhat S, Nunes D. Pharmacist-ManagedHelicobacter pyloriTreatment Service Within a Gastroenterology Clinic: Workflow and Real-World Experiences[J]. Ann Pharmacother, 2022, 56(2): 162-169.
|
[3] |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等.幽门螺杆菌感染基层诊疗指南(2019年)[J]. 中华全科医师杂志,2020, 19(5): 397-402.
|
[4] |
陈琦, 方颖, 梁晓, 等. 中国自然人群筛查与伺机性检测策略预防幽门螺杆菌相关疾病的卫生经济学评价[J]. 中华消化杂志,2021, 41(4): 234-240.
|
[5] |
张诗情, 吴小微. 幽门螺杆菌与消化系统外疾病的相关性及其治疗进展[J]. 临床消化病杂志, 2022, 34(2): 138-143.
|
[6] |
罗举, 蔡昊, 徐灿霞. 幽门螺杆菌感染与心血管疾病的研究进展[J]. 中华内科杂志, 2022, 61(1): 121-125.
|
[7] |
Gunaratne A W, Hamblin H, Clancy A, et al. Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study[J]. Helicobacter, 2021, 26(5): e12830.
|
[8] |
Oster P, Vaillant L, Riva E, et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies[J].Gut, 2022, 71(3): 457-466.
|
[9] |
国家消化系疾病临床医学研究中心(上海), 中华医学会健康管理学分会, 中华医学会核医学分会. 幽门螺杆菌-尿素呼气试验临床应用专家共识(2020年)[J]. 中华消化杂志, 2020, 40(12): 797-802.
|
[10] |
Jung HK, Kang SJ, Lee YC, et al. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020[J]. Korean J Intern Med, 2021, 36(4): 807-838.
|
[11] |
杨骥, 王嫱. 体检人群14C呼气检测阳性跟踪随访与胃癌的相关性[J]. 标记免疫分析与临床, 2022, 29(8): 1354-1358.
|
[12] |
Zhang W, Liang X, Chen X, et al. Time trends in the prevalence of Helicobacter pylori infection in patients with peptic ulcer disease: a single-center retrospective study in Shanghai[J]. J Int Med Res, 2021,49(10): 3000605211051167.
|
[13] |
薛建华, 俞海萍, 单雪晴, 等. 上海地区职业人群幽门螺杆菌感染现状及其影响因素[J]. 环境与职业医学, 2021, 38(3): 272-277.
|
[14] |
田宏扬, 严华芳, 乔春萍, 等. 上海市浦东新区南部体检人群幽门螺杆菌感染情况及相关因素分析[J]. 复旦学报(医学版), 2022, 49(5): 1-7.
|
[15] |
狄佳, 常丹燕, 刘莎, 等. 西安地区1万例门诊和体检人群幽门螺杆菌感染现状调查与危险因素分析[J]. 中国中西医结合消化杂志, 2022, 30(3): 200-206.
|
[16] |
张宜青, 赵春英, 孙召君, 等. 10000例天津地区健康体检人群幽门螺杆菌感染率及相关影响因素分析[J]. 健康体检与管理, 2021,2(2), 115-118.
|
[17] |
董洁, 冯晓青, 霍宏, 等. 北京地区胃癌高危人群早发现早诊治认知情况调查及影响因素[J]. 华南预防医学, 2022, 48(6): 674-677.
|
[18] |
中华医学会消化病学分会幽门螺杆菌学组. 2022中国幽门螺杆菌感染治疗指南[J]. 中华消化杂志, 2022, 42(11): 745-756.
|
[19] |
Losurdo G, Ierardi E, Leo AD. Helicobacter pylori antibiotic resistance: stewardship, tailored therapies and future perspectives[J].Gastroenterology, 2021, 161(3): 1071-1072.
|
[20] |
Zurita J, Sevillano G, Mio A, et al. Mutations associated with Helicobacter pylori antimicrobial resistance in the Ecuadorian population[J]. J Appl Microbiol, 2022, 132(4): 2694-2704.
|
[21] |
Maubach G, Vieth M, Boccellato F, et al. Helicobacter pyloriinduced NF-KB: trailblazer for gastric pathophysiology[J]. Trends Mol Med, 2022, 28(3): 210-222.
|
[22] |
Zhao M, Jiang Y, Chen Z, et al. Traditional Chinese medicine for Helicobacter pylori infection: A protocol for a systematic review and meta-analysis[J]. Medicine, 2021, 100(3): e24282.
|